DelMar Pharmaceuticals

$0.7149
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0758 (11.92%) Today
+$0.0032 (0.45%) As of 4:20 PM EDT after-hours

Why Robinhood?

You can buy or sell DMPI and other stocks, options, ETFs, and crypto commission-free!

About DMPI

DelMar Pharmaceuticals, Inc. Common Stock, also called DelMar Pharmaceuticals, is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. Read More It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.

Employees
17
Headquarters
San Diego, California
Founded
2009
Market Cap
1.86M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
465.72K
High Today
$0.7348
Low Today
$0.63
Open Price
$0.632
Volume
719.55K
52 Week High
$8.50
52 Week Low
$0.552

Collections

DMPI Earnings

-$0.89
-$0.62
-$0.35
-$0.08
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
-$0.89 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.